Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANTIHEMOPHILIC FACTOR HUMAN for Immune tolerance induction: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 18 adverse event reports in the FDA FAERS database where ANTIHEMOPHILIC FACTOR HUMAN was used for Immune tolerance induction.

Most Reported Side Effects for ANTIHEMOPHILIC FACTOR HUMAN

Side Effect Reports % Deaths Hosp.
Haemarthrosis 118 14.6% 5 26
Haemorrhage 112 13.8% 5 37
Drug ineffective 69 8.5% 5 14
No adverse event 64 7.9% 1 10
Epistaxis 43 5.3% 1 11
Acquired haemophilia 41 5.1% 41 14
Arthralgia 40 4.9% 2 12
Fall 37 4.6% 1 18
Device issue 36 4.5% 1 1
Pre-existing disease 36 4.5% 36 13
Therapy partial responder 36 4.5% 35 13
Pain 34 4.2% 1 11
Product preparation issue 34 4.2% 1 1
Drug ineffective for unapproved indication 27 3.3% 2 6
Contusion 25 3.1% 0 13

Other Indications for ANTIHEMOPHILIC FACTOR HUMAN

Von willebrand's disease (228) Product used for unknown indication (187) Factor viii deficiency (161) Prophylaxis (68) Haemorrhage (44) Haemophilia (34) Acquired haemophilia (33) Gastrointestinal haemorrhage (10) Coagulopathy (9) Acquired von willebrand's disease (7)

Other Drugs Used for Immune tolerance induction

RITUXIMAB (207) HUMAN IMMUNOGLOBULIN G (88) ASPIRIN (62) MYCOPHENOLATE MOFETIL (62) ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (53) --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (52) EFMOROCTOCOG ALFA (46) PHLEUM PRATENSE POLLEN (36) BORTEZOMIB (35) OXALIPLATIN (33)

Related Pages

ANTIHEMOPHILIC FACTOR HUMAN Full Profile All Immune tolerance induction Drugs ANTIHEMOPHILIC FACTOR HUMAN Demographics ANTIHEMOPHILIC FACTOR HUMAN Timeline